Practice
Featured experience
Bristol Myers Squibb $13 billion notes offering
The investment-grade offering comprised nine tranches
Cisco Systems $13.5 billion notes offering
The investment-grade offering comprises seven tranches of notes
Galderma Group CHF2.3 billion ($2.6 billion) IPO
We advised Galderma on its IPO
Novartis $3.7 billion notes offering
We advised Novartis on the investment-grade debt offering
Korro Bio $70 million private placement
The PIPE consists of common stock
Baicha Baidao HK$2.6 billion IPO
We advised Baicha Baidao on its IPO and HKEX listing
TScan Therapeutics $150 million stock and pre-funded warrants offering
The stock is listed on the Nasdaq Global Market
Cohen & Steers $100 million at-the-market offering
The shares are listed on the NYSE
Intra-Cellular Therapies $500 million stock offering
The shares are listed on the Nasdaq Global Select Market
Avolta €500 million notes offering and cash tender offer
We advised Avolta on its high-yield notes offering and tender offer
Morgan Stanley $8 billion senior notes offering
We advised Morgan Stanley on its SEC-registered global offering
Barratt Developments £2.52 billion all-share offer for Redrow
We are advising UBS as financial adviser and sponsor to Barratt Developments on the transaction
Circle smart contract for real-time transfers of new tokenized BlackRock fund
We advised Circle on launching a smart contract enabling transfers of BlackRock’s tokenized fund over the Ethereum Network
Galaxy C$169.4 million offering of ordinary shares
We advised Galaxy on its offering